IP
CRCST-L-0001
Phase 3 small_molecule completed
Quick answer
IP for Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Solid Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed